Multiple embryonic origins of gonadotropin-releasing hormone (GnRH) immunoreactive neurons. 1994

R G Northcutt, and L E Muske
Neurobiology Unit-Scripps Institute of Oceanography, University of California at San Diego, La Jolla 90201.

Experiments were conducted to test the hypothesis that gonadotropin-releasing hormone immunoreactive (GnRH-ir) and FMRFamide-ir neurons present in the brain and nervus terminalis originate in the embryonic olfactory placode. The olfactory placodes were bilaterally extirpated in stage 26 or stage 29 embryos of the axolotl, Ambystoma mexicanum, which were then reared for 4-8 months before they were examined immunohistochemically. In experimental subjects with bilateral loss of olfactory epithelia, nerves and bulbs, there was complete absence of GnRH- and FMRFamide-ir neurons in the terminal nerve, and in septal and preoptic areas, and complete absence of large diameter peptidergic fibers associated with the TN-septo-preoptic system. However, GnRH-ir perikarya in the posterior tubercle, and FMRFamide-ir perikarya in the ventral hypothalamus, and small diameter peptidergic fibers were not affected by placodal ablation. These results support the hypothesis that contrary to recent reports, GnRH-ir neurons have more than one embryonic origin. Region-specific patterns of staining with antisera directed against different molecular forms of GnRH support the interpretation that GnRH-ir neurons of placodal origin express mammalian GnRH, whereas GnRH-ir neurons of non-placodal origin, in the posterior tubercle, express chicken GnRH II.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004625 Embryo, Nonmammalian The developmental entity of a fertilized egg (ZYGOTE) in animal species other than MAMMALS. For chickens, use CHICK EMBRYO. Embryonic Structures, Nonmammalian,Embryo, Non-Mammalian,Embryonic Structures, Non-Mammalian,Nonmammalian Embryo,Nonmammalian Embryo Structures,Nonmammalian Embryonic Structures,Embryo Structure, Nonmammalian,Embryo Structures, Nonmammalian,Embryo, Non Mammalian,Embryonic Structure, Non-Mammalian,Embryonic Structure, Nonmammalian,Embryonic Structures, Non Mammalian,Embryos, Non-Mammalian,Embryos, Nonmammalian,Non-Mammalian Embryo,Non-Mammalian Embryonic Structure,Non-Mammalian Embryonic Structures,Non-Mammalian Embryos,Nonmammalian Embryo Structure,Nonmammalian Embryonic Structure,Nonmammalian Embryos,Structure, Non-Mammalian Embryonic,Structure, Nonmammalian Embryo,Structure, Nonmammalian Embryonic,Structures, Non-Mammalian Embryonic,Structures, Nonmammalian Embryo,Structures, Nonmammalian Embryonic
D000558 Ambystoma mexicanum A salamander found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research. The axolotl remains in larval form throughout its life, a phenomenon known as neoteny. Axolotl,Mexican Salamander,Ambystoma mexicanums,Axolotls,Salamander, Mexican,mexicanums, Ambystoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D019835 FMRFamide A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3) FMRF,FMRF-NH2,FMRF-amide,FMRFamide, (D-Arg)-Isomer,FMRFamide, (D-Met)-Isomer,FMRFamide, (D-Phe)-Isomer,FMRFamide, (D-phenylalanine)-Isomer,Phe-Met-Arg-Phe-NH2,Phe-Met-Arg-Phe-amide,FMRF NH2,FMRF amide,Phe Met Arg Phe amide

Related Publications

R G Northcutt, and L E Muske
July 2004, The European journal of neuroscience,
R G Northcutt, and L E Muske
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
R G Northcutt, and L E Muske
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
R G Northcutt, and L E Muske
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
R G Northcutt, and L E Muske
February 1985, The Journal of comparative neurology,
Copied contents to your clipboard!